Cargando…

Lead Generation and Optimization Based on Protein-Ligand Complementarity

This work proposes a computational procedure for structure-based lead generation and optimization, which relies on the complementarity of the protein-ligand interactions. This procedure takes as input the known structure of a protein-ligand complex. Retaining the positions of the ligand heavy atoms...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogata, Koji, Isomura, Tetsu, Kawata, Shinji, Yamashita, Hiroshi, Kubodera, Hideo, Wodak, Shoshana J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264460/
https://www.ncbi.nlm.nih.gov/pubmed/20657448
http://dx.doi.org/10.3390/molecules15064382
_version_ 1783375501843234816
author Ogata, Koji
Isomura, Tetsu
Kawata, Shinji
Yamashita, Hiroshi
Kubodera, Hideo
Wodak, Shoshana J.
author_facet Ogata, Koji
Isomura, Tetsu
Kawata, Shinji
Yamashita, Hiroshi
Kubodera, Hideo
Wodak, Shoshana J.
author_sort Ogata, Koji
collection PubMed
description This work proposes a computational procedure for structure-based lead generation and optimization, which relies on the complementarity of the protein-ligand interactions. This procedure takes as input the known structure of a protein-ligand complex. Retaining the positions of the ligand heavy atoms in the protein binding site it designs structurally similar compounds considering all possible combinations of atomic species (N, C, O, CH(3,) NH, etc). Compounds are ranked based on a score which incorporates energetic contributions evaluated using molecular mechanics force fields. This procedure was used to design new inhibitor molecules for three serine/threonine protein kinases (p38 MAP kinase, p42 MAP kinase (ERK2), and c-Jun N-terminal kinase 3 (JNK3)). For each enzyme, the calculations produce a set of potential inhibitors whose scores are in agreement with IC50 data and Ki values. Furthermore, the native ligands for each protein target, scored within the five top-ranking compounds predicted by our method, one of the top-ranking compounds predicted to inhibit JNK3 was synthesized and his inhibitory activity confirmed against ATP hydrolysis. Our computational procedure is therefore deemed to be a useful tool for generating chemically diverse molecules active against known target proteins.
format Online
Article
Text
id pubmed-6264460
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62644602018-12-04 Lead Generation and Optimization Based on Protein-Ligand Complementarity Ogata, Koji Isomura, Tetsu Kawata, Shinji Yamashita, Hiroshi Kubodera, Hideo Wodak, Shoshana J. Molecules Article This work proposes a computational procedure for structure-based lead generation and optimization, which relies on the complementarity of the protein-ligand interactions. This procedure takes as input the known structure of a protein-ligand complex. Retaining the positions of the ligand heavy atoms in the protein binding site it designs structurally similar compounds considering all possible combinations of atomic species (N, C, O, CH(3,) NH, etc). Compounds are ranked based on a score which incorporates energetic contributions evaluated using molecular mechanics force fields. This procedure was used to design new inhibitor molecules for three serine/threonine protein kinases (p38 MAP kinase, p42 MAP kinase (ERK2), and c-Jun N-terminal kinase 3 (JNK3)). For each enzyme, the calculations produce a set of potential inhibitors whose scores are in agreement with IC50 data and Ki values. Furthermore, the native ligands for each protein target, scored within the five top-ranking compounds predicted by our method, one of the top-ranking compounds predicted to inhibit JNK3 was synthesized and his inhibitory activity confirmed against ATP hydrolysis. Our computational procedure is therefore deemed to be a useful tool for generating chemically diverse molecules active against known target proteins. MDPI 2010-06-17 /pmc/articles/PMC6264460/ /pubmed/20657448 http://dx.doi.org/10.3390/molecules15064382 Text en © 2010 by the authors; licensee MDPI, Basel, Switzerland. This article is an Open Access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Ogata, Koji
Isomura, Tetsu
Kawata, Shinji
Yamashita, Hiroshi
Kubodera, Hideo
Wodak, Shoshana J.
Lead Generation and Optimization Based on Protein-Ligand Complementarity
title Lead Generation and Optimization Based on Protein-Ligand Complementarity
title_full Lead Generation and Optimization Based on Protein-Ligand Complementarity
title_fullStr Lead Generation and Optimization Based on Protein-Ligand Complementarity
title_full_unstemmed Lead Generation and Optimization Based on Protein-Ligand Complementarity
title_short Lead Generation and Optimization Based on Protein-Ligand Complementarity
title_sort lead generation and optimization based on protein-ligand complementarity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264460/
https://www.ncbi.nlm.nih.gov/pubmed/20657448
http://dx.doi.org/10.3390/molecules15064382
work_keys_str_mv AT ogatakoji leadgenerationandoptimizationbasedonproteinligandcomplementarity
AT isomuratetsu leadgenerationandoptimizationbasedonproteinligandcomplementarity
AT kawatashinji leadgenerationandoptimizationbasedonproteinligandcomplementarity
AT yamashitahiroshi leadgenerationandoptimizationbasedonproteinligandcomplementarity
AT kuboderahideo leadgenerationandoptimizationbasedonproteinligandcomplementarity
AT wodakshoshanaj leadgenerationandoptimizationbasedonproteinligandcomplementarity